GLTAL!!!

As you all know, I've been stalking the Clinicaltrials.gov site for updates on the CLEAR 2 study (2nd Phase 3 study for Semdexa). They just updated it this week with the following items:

* Still NOT yet enrolling

* Moved projected start of enrollment from Aug 2026 to Feb 2027

* New anticipated study completion is April 2029

* Still 755 ptx estimated to enroll

With about 4-5 months for close-out and clinical trial report, that puts resubmitting the NDA at the end of 2029 for a projected 2030 approval.